Home Services Exosome Services Exosome Characterization Services

Exosome Characterization Services

Combine morphology, particle size and concentration, marker identity, and optional molecular analysis in a project-specific characterization plan.

Compare Methods
MorphologyTEM · Cryo-TEM · SEM
Size & CountNTA · DLS · TRPS
IdentityWB · Flow Cytometry · FACS
Cutaway illustration of an exosome showing its lipid membrane, surface proteins, and internal cargo

What Is Exosome Characterization?

Exosome characterization combines complementary analytical methods to assess vesicle morphology, size distribution, particle concentration, and marker identity. It matters because no single measurement can establish exosome identity or determine whether a preparation is suitable for downstream research.

Exosomes are heterogeneous nanoscale vesicles. A robust characterization plan should examine complementary properties instead of relying on a single readout.

Creative Biostructure typically organizes characterization at three levels: morphology, size and size distribution, and surface-marker identification. Optional methods can extend the analysis to particle concentration, surface properties, cargo, or molecular composition.

Complementary evidence

Morphology shows particle appearance; NTA, DLS, or TRPS describe particle behavior and size; marker assays evaluate proteins associated with the vesicle preparation.

Orthogonal confirmation

Each technique answers a different question and has distinct limitations. Combining readouts reduces overinterpretation and creates a more defensible description of the sample.

Research-ready decisions

Results can inform preparation comparison, quality review, method selection, downstream assay planning, and reporting for exosome research projects.

Characterization capabilities

Build the right analytical panel

Begin with the property you need to establish, then combine complementary methods to strengthen interpretation.

TEM and cryo-TEM images for exosome morphology characterization
01 · Morphology

Electron Microscopy

Visualize vesicle morphology, membrane integrity, and particle appearance.

TEMCryo-TEMSEM
Nanoparticle tracking analysis result for exosome size distribution
02 · Size & concentration

Nanoparticle Tracking Analysis

Measure particle size distribution and concentration in liquid suspension.

NTAParticle count
Western blot analysis of exosome marker proteins
03 · Identity

Marker Protein Analysis

Evaluate CD9, CD63, CD81, TSG101, ALIX, HSP70, and project-specific markers.

Western BlotFlow CytometryFACS
Advanced analysis of exosome surface and molecular properties
04 · Orthogonal analysis

Advanced Characterization

Add complementary size, surface, biomechanical, or molecular-composition data.

DLSTRPSAFMMS

Method selection guide

Match each question to the right evidence

No single assay answers every characterization question. Use the comparison below to identify an appropriate starting panel.

Research question Recommended method Primary readout Important consideration
What do the vesicles look like? TEM / Cryo-TEM / SEM Morphology and structural appearance Preparation influences interpretation
What is the size distribution and concentration? NTA Particle size profile and count Does not prove exosome identity
Is the suspension relatively monodisperse? DLS Hydrodynamic size and distribution Best for relatively uniform suspensions
Which vesicle markers are present? Western blot / Flow Cytometry / FACS Marker detection or expression profile Panel should fit the sample source
What is the molecular composition? Mass spectrometry Protein or molecular-composition data Scope depends on sample and objective
Not sure what to combine?

Send your sample source, isolation method, available amount, and downstream objective.

Integrated Exosome Characterization Platform

Capability Details
Morphology &
Ultrastructure
TEM, Cryo-TEM, and SEM visualize vesicle morphology, membrane preservation, particle appearance, and aggregation. Imaging strategy and sample preparation are selected to fit the question.
Particle Size &
Concentration
NTA measures particle-size distribution and concentration. DLS and TRPS can add complementary hydrodynamic-size or single-particle information when appropriate.
Marker Identity &
Phenotyping
Western blot, flow cytometry/FACS, and immunoelectron microscopy evaluate exosome-associated and project-specific markers using a panel matched to the sample source.
Surface &
Nanoscale Properties
AFM provides complementary surface-topography and nanoscale-property information for projects that require more than routine morphology and particle analysis.
Molecular Composition Mass spectrometry can extend the study to protein or broader molecular-composition questions, with analytical scope defined by sample quality, available material, and the research objective.
Thermo Scientific Krios G4

Thermo Scientific Krios G4

NanoSight Pro NTA particle size analyzers

NanoSight Pro NTA particle size analyzers

BD FACSAria™ Fusion Flow Cytometer

BD FACSAria™ Fusion Flow Cytometer

Bruker Dimension Icon AFM

Bruker Dimension Icon AFM

Thermo Scientific Orbitrap Exploris 480

Thermo Scientific Orbitrap Exploris 480

Project workflow

From sample context to interpretable results

Each method is selected to answer an explicit scientific question, with limitations and outputs defined before testing begins.

  1. 01
    Project review

    Sample source, preparation history, prior results, and downstream goal.

  2. 02
    Sample and method assessment

    Confirm method fit and project-specific handling requirements.

  3. 03
    Analytical testing

    Perform agreed morphology, particle, marker, or composition methods.

  4. 04
    Quality review

    Review controls, consistency, and assay-specific limitations.

  5. 05
    Reporting and interpretation

    Organize results around the agreed research question.

Representative NTA particle-size distribution output
Representative analytical outputNTA particle-size distribution

Clear project outputs

Data that can move your study forward

Deliverables are defined with the selected methods and may include representative images, plots, marker data, method summaries, and scientific interpretation.

01

Method-specific resultsImages, profiles, plots, blots, or datasets according to the agreed panel.

02

Quality and interpretation notesContext for controls, assay limitations, and complementary evidence.

03

Organized project reportA consolidated record of methods, results, and project-specific conclusions.

Client publication case study

TEM-Verified hucMSC Exosomes in a Cardiomyocyte Hypoxia/Reoxygenation Model

A peer-reviewed study used transmission electron microscopy performed at Creative Biostructure to check extracted hucMSC exosomes before evaluating their effects in an in vitro cardiomyocyte injury model.

Research question

Hypoxia/reoxygenation can activate the NLRP3 inflammasome and drive inflammatory cell death in cardiomyocytes. The investigators asked whether human umbilical cord mesenchymal stem cell-derived exosomes could reduce this injury and whether exosomal miR-100-5p acted through the FOXO3/NLRP3 pathway.

Study design and analytical methods

  • hucMSC-conditioned medium was clarified, filtered, and processed for exosome isolation; extracted exosomes were resuspended in PBS.
  • Exosome morphology was checked by TEM at Creative Biostructure. CD9, CD63, and Alix were evaluated by Western blot.
  • AC16 cardiomyocytes underwent 4 hours at 1% O2 followed by 2 hours at 20% O2 to model hypoxia/reoxygenation injury.
  • Exosomes from miR-100-5p mimic-, inhibitor-, or negative-control-transfected hucMSCs were compared using viability, LDH, Hoechst/PI staining, qRT-PCR, Western blot, cytokine, and luciferase assays.

Key findings reported by the authors

Figure 1. Morphology of purified hucMSC-exo. Scale bar: 100 nm
  • Hypoxia/reoxygenation reduced AC16 cell viability and increased LDH release, PI-positive cells, NLRP3, activated caspase-1, GSDMD-N, IL-1β, and IL-18.
  • hucMSC exosome treatment attenuated these injury and pyroptosis-associated readouts.
  • Exosomes enriched in miR-100-5p produced stronger protective effects, while exosomes from miR-100-5p-inhibited cells showed weaker effects.
  • miR-100-5p bound the FOXO3 3′-UTR, and FOXO3 overexpression counteracted the observed protection.

Interpretation

The authors concluded that miR-100-5p-enriched hucMSC exosomes suppressed FOXO3 expression, reduced NLRP3 inflammasome activation and cytokine release, and protected cardiomyocytes from hypoxia/reoxygenation-induced pyroptosis in vitro.

Frequently asked questions

What to know before sending a sample

Requirements depend on the methods selected. A short technical review is the fastest way to define the right panel.

View All FAQs →

Creative Biostructure offers NTA, TEM and Cryo-TEM, SEM, Western blot, flow cytometry/FACS, DLS, TRPS, AFM, immunoelectron microscopy, and mass spectrometry. The recommended panel depends on the sample and research objective.

Publications

Published Research and Scientific Context

These publications provide traceable scientific context for exosome characterization and document Creative Biostructure services or contributions cited by researchers.

  1. 01

    Characterization and Fine Structure of Exosomes

    Al-shubaily, F. A., & Al-Zahrani, M. H. (2021). In Role of Exosomes in Biological Communication Systems, 27-75.

    Scientific chapter discussing exosome structure and characterization approaches, with reference to Creative Biostructure characterization technology.

    View DOI ↗
  2. 02

    Exosomes of Human Umbilical Cord MSCs Protect Against Hypoxia/Reoxygenation-Induced Pyroptosis of Cardiomyocytes via the miRNA-100-5p/FOXO3/NLRP3 Pathway

    Liang, C., et al. (2021). Frontiers in Bioengineering and Biotechnology, 8, 615850.

    The authors report that extracted hucMSC exosomes were checked by TEM at Creative Biostructure before functional testing.

    View DOI ↗
  3. 03

    Characterization of Extracellular Vesicles Isolated from Human Milk Using a Precipitation-Based Method

    Bickmore, D. C., & Miklavcic, J. J. (2020). Frontiers in Nutrition, 7, 22.

    The publication reports fatty acid analysis performed by Creative Biostructure as part of a human-milk extracellular-vesicle study.

    View DOI ↗
More Publications →

References

  1. Van Niel, et al. Shedding light on the cell biology of extracellular vesicles. Nature Reviews Molecular Cell Biology. 2018, 19(4): 213-228.
  2. Chen Zhang, et al. Plasma exosomal miR-375-3p regulates mitochondria-dependent keratinocyte apoptosis by targeting XIAP in severe drug-induced skin reactions. Science Translational Medicine. Sci Transl Med. 2020, 12(574): eaaw6142.
  3. Anton Emelyanov, et al. Cryo-electron microscopy of extracellular vesicles from cerebrospinal fluid. PLoS One. 2020, 15(1): e0227949.
OUR VALUED PARTNERSHIPS
mit harvard stanford nih abbvie novartis amgen gsk regeneron sanofi
Online Inquiry

For Research or Industrial Raw Materials, Not for Personal Use!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Download Resource

Please fill in your information to download this resource.